During the past decade, Centre hospitalier de Soissons conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre hospitalier de Soissons" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 2 trials, followed by "ARCAGY/ GINECO GROUP" with 1 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored, "Groupe Hospitalier de la Region de Mulhouse et Sud Alsace" with 1 trials sponsored and "Hopital Foch" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre hospitalier de Soissons" #1 collaborator was "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "Institut National de la Santé et de la Recherche Médical (INSERM) 1086 (Pr Guy LAUNOY) Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Pierre Fabre Laboratories" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre hospitalier de Soissons" are "Atrial Arrhythmia" (1 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials), "Carcinoma" (1 trials) and "Clinical Research" (1 trials). Many other conditions were trialed in "Centre hospitalier de Soissons" in a lesser frequency.

Most popular intervention types in "Centre hospitalier de Soissons" are "Drug" (4 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "5-Fluoro-uracil" (1 trials), "Anastrozole" (1 trials), "Avelumab" (1 trials) and "Early consideration of vulnerability" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre hospitalier de Soissons" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre hospitalier de Soissons". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre hospitalier de Soissons, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre hospitalier de Soissons, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".